127 related articles for article (PubMed ID: 38859837)
41. Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression.
Song Z; Cao Q; Guo B; Zhao Y; Li X; Lou N; Zhu C; Luo G; Peng S; Li G; Chen K; Wang Y; Ruan H; Guo Y
Aging Dis; 2023 Oct; 14(5):1757-1774. PubMed ID: 37196108
[TBL] [Abstract][Full Text] [Related]
42. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
43. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
44. Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.
Owens JL; Beketova E; Liu S; Shen Q; Pawar JS; Asberry AM; Yang J; Deng X; Elzey BD; Ratliff TL; Cheng L; Choo R; Citrin DE; Polascik TJ; Wang B; Huang J; Li C; Wan J; Hu CD
Mol Cancer Ther; 2022 Mar; 21(3):448-459. PubMed ID: 35027481
[TBL] [Abstract][Full Text] [Related]
45. NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis.
Yao C; Cheng X; Guo X; Lu X; Bu F; Xu Y
Cancer Cell Int; 2020; 20():463. PubMed ID: 32982585
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.
Delk NA; Farach-Carson MC
Autophagy; 2012 Apr; 8(4):650-63. PubMed ID: 22441019
[TBL] [Abstract][Full Text] [Related]
47. LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression.
Ye C; Qin S; Guo F; Yang Y; Wang H; Zhang C; Yang B
J Cancer; 2022; 13(1):146-152. PubMed ID: 34976178
[TBL] [Abstract][Full Text] [Related]
48. Smoothened loss is a characteristic of neuroendocrine prostate cancer.
Wang L; Li H; Li Z; Li M; Tang Q; Wu C; Lu Z
Prostate; 2021 Jun; 81(9):508-520. PubMed ID: 33955576
[TBL] [Abstract][Full Text] [Related]
49. A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression
Liu B; Qian D; Zhou W; Jiang H; Xiang Z; Wu D
Front Oncol; 2020; 10():620306. PubMed ID: 33614501
[TBL] [Abstract][Full Text] [Related]
50. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling.
Luo J; Wang K; Yeh S; Sun Y; Liang L; Xiao Y; Xu W; Niu Y; Cheng L; Maity SN; Jiang R; Chang C
Nat Commun; 2019 Jun; 10(1):2571. PubMed ID: 31189930
[TBL] [Abstract][Full Text] [Related]
51. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.
Li Y; Donmez N; Sahinalp C; Xie N; Wang Y; Xue H; Mo F; Beltran H; Gleave M; Wang Y; Collins C; Dong X
Eur Urol; 2017 Jan; 71(1):68-78. PubMed ID: 27180064
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-1205 Regulation of FRYL in Prostate Cancer.
Naidoo M; Levine F; Gillot T; Orunmuyi AT; Olapade-Olaopa EO; Ali T; Krampis K; Pan C; Dorsaint P; Sboner A; Ogunwobi OO
Front Cell Dev Biol; 2021; 9():647485. PubMed ID: 34386489
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA SAP30L-AS1 promotes prostate cancer growth through repressing SAP30L.
Qin X; Zhu W; Lu A; Wang G; Ye X; Weng G
Gene; 2019 Mar; 690():120-128. PubMed ID: 30599235
[TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis.
Zhang T; Ji T; Duan Z; Xue Y
Sci Rep; 2024 Mar; 14(1):6379. PubMed ID: 38493244
[TBL] [Abstract][Full Text] [Related]
55. PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
Liu B; Li L; Yang G; Geng C; Luo Y; Wu W; Manyam GC; Korentzelos D; Park S; Tang Z; Wu C; Dong Z; Sigouros M; Sboner A; Beltran H; Chen Y; Corn PG; Tetzlaff MT; Troncoso P; Broom B; Thompson TC
Clin Cancer Res; 2019 Nov; 25(22):6839-6851. PubMed ID: 31439587
[TBL] [Abstract][Full Text] [Related]
56. Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.
Misawa A; Takayama K; Urano T; Inoue S
J Biol Chem; 2016 Aug; 291(34):17861-80. PubMed ID: 27342777
[TBL] [Abstract][Full Text] [Related]
57. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
[TBL] [Abstract][Full Text] [Related]
58. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.
Wu X; Xiao Y; Zhou Y; Zhou Z; Yan W
Cell Death Dis; 2019 Jun; 10(7):472. PubMed ID: 31209207
[TBL] [Abstract][Full Text] [Related]
59. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
60. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Zhao Z; Liang S; Sun F
Front Oncol; 2020; 10():1172. PubMed ID: 32850336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
